Citigroup Maintains Neutral on QuidelOrtho, Lowers Price Target to $13

Quidel Corporation

Quidel Corporation

QDEL

0.00

Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ: QDEL) with a Neutral and lowers the price target from $30 to $13.